PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Histone methyltransferase G9a protects against acute liver injury through GSTP1.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31515511 ↗2019Reported benefit

Histone methyltransferase G9a protects against acute liver injury through GSTP1.

MouseEndotoxin/LPSC57BL/6, including liver-specific G9a-deficient (L-G9a) mice and littermate controlsmale for D-galactosamine/lipopolysaccharide and acetaminophen experiments; male and female for lipopolysaccharide-only injectionrGSTP1 intravenous; BIX intraperitonealrGSTP1 10 mg/kg; BIX 50 mg/kg body weightrGSTP1 given 30 min before lipopolysaccharide or acetaminophen injection; BIX g…

Model: D-galactosamine (200 mg/kg body weight, intraperitoneal) plus lipopolysaccharide (3 mg/kg body weight, intraperitoneal) induced acute liver injury; and acetaminophen overdose (400 mg/kg body weight, intraperitoneal, after overnight fasting)

Liver-specific G9a deletion caused 100 per cent mortality after lipopolysaccharide under D-galactosamine sensitisation and worsened acetaminophen-induced injury, and treatment with recombinant GSTP1 reversed the liver damage in G9a-deficient mice, identifying a protective G9a-GSTP1 axis.

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.